SCHEMBL4872188

SCHEMBL4872188

CC[C@@H]1C(=O)Nc2cc(F)ccc2N1C(=O)c1ccc(OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
MAPT P10636 2/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 2/20 0.41
TSHR P16473 2/20 0.41
BRD4 O60885 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 2/20 0.39
THRB P10828 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD11B1 P28845 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4870381 0.92 MAPK1 (0.48) MAPK1MAPTKMT2AMEN1ALDH1A1
SCHEMBL4916100 0.92 MAPK1 (0.48) MAPK1MAPTKMT2AMEN1ALDH1A1
SCHEMBL4870172 0.92 MAPK1 (0.48) MAPK1MAPTKMT2AMEN1ALDH1A1
SCHEMBL4864118 0.89 KMT2A (0.48) MAPK1MAPTKMT2AMEN1ALDH1A1
SCHEMBL4867889 0.80 SMN1; SMN2 (0.43) MAPTALDH1A1HTTLMNATSHR
SCHEMBL4870374 0.80 SMN1; SMN2 (0.43) MAPTALDH1A1HTTLMNATSHR
SCHEMBL4866466 0.80 SMN1; SMN2 (0.43) MAPTALDH1A1HTTLMNATSHR
SCHEMBL4870059 0.79 USP2 (0.45) MAPTKMT2AMEN1ALDH1A1HTT
SCHEMBL4867553 0.79 USP2 (0.45) MAPTKMT2AMEN1ALDH1A1HTT
SCHEMBL4864075 0.79 USP2 (0.45) MAPTKMT2AMEN1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351709-B2 Estrogen receptor ligands WYETH (US) 2008-04-01 US disclosed
US-20060019961-A1 Estrogen receptor ligands WYETH 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019961-A1 Estrogen receptor ligands GPER1, ESR2, ESR1 MAPK1 3459/4885MAPT 3994/4885KMT2A 2436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.